Kappa Bioscience
Search


Searchresults

Bioequivalence

... Currently, about 30% of K2 MK-7 ingredient production is based on synthesis and the remainder on a fermentation process. This will change. Synthesis production provides several advantages over fermentation production....

k2-academy/bioequivalence/#c526

Bioequivalence

... The Møller study has proven that all benefits obtained with the natural-fermented MK-7 are equally valid for K2VITAL® fileadmin/content/factsheets/11-Bioequivalence/vitamin-production-graph.png right middle 1 1 1

k2-academy/bioequivalence/#c525

Bioequivalence

... Fermentation-derived K2 products have been shown in clinical studies to prevent and reverse arterial calcification and improve bone mineral density in healthy postmenopausal women. Since K2VITAL® is a synthetic MK-7...

k2-academy/bioequivalence/#c524

Bioequivalence

... The Møller study demonstrated that K2VITAL® is bioequivalent to the natural-fermented K2 fileadmin/content/factsheets/11-Bioequivalence/moller-study-graph.png right middle 1 1 1

k2-academy/bioequivalence/#c523

Bioequivalence

... molecule Ingredient purity is enhanced significantly by synthesis production compared to fermentation. Synthesis creates a pure, all-trans molecule that is free of the impurities typically present...

k2-academy/bioequivalence/#c745

K2 Stability

... economical solution for those market categories relying on calcium or magnesium. Compared to natural-fermented K2 MK-7, K2VITAL® DELTA is stable because of its double- coated protection. K2VITAL® DELTA offers...

k2-academy/k2-stability/#c539

Daily Dosage & Overage

... Overdose recommendations for fermentation-derived K2 and microencapsulated K2VITAL® DELTA when combined with other ingredients in formulation fileadmin/content/factsheets/15-Daily-Dosage-And-Overdosage/Asset-1.png...

k2-academy/daily-dosage-overage/#c699
Search results 11 until 17 of 17

Customer Download Portal

Sign up | Reset password

Sales and Marketing
Kappa Ingredients GmbH
Deichstrasse 29 | 20459 Hamburg
Germany

Headquarter
Kappa Bioscience AS
Silurveien 2 | Building B | 0380 Oslo
Norway

+49 40 6094087 0